NCT03502395View on ClinicalTrials.gov

Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

January 21, 2018

Study Completion Date

February 13, 2018

Conditions
Cancer, Breast
Interventions
DRUG

Lidocaine

): Patients were received intravenous 1 mg/kg of 2 % lidocaine as a loading dose (just before induction of anesthesia) then received 2mg/kg /h lidocaine as maintenance dose (with maximum of 200 mg/h) till the end of the operation (skin closure).

DRUG

Normal saline

A standardized equal volume of intravenous bolus dose of normal saline was given as loading dose then normal saline was administered on an equal rate of infusion.

Trial Locations (1)

Unknown

Assiut university faculty of medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03502395 - Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion | Biotech Hunter | Biotech Hunter